For several CRMs, such as PRMT5 and MINA, the interaction with MYC was reported to be an essential step in cancer development (Additional file 5: Table S1, references 31, 32, 36–39 (listed in Additional file 6)). The gene discussed is RIOX2; the disease is cancer.